Intra-Cellular Therapies

Intra-Cellular Therapies

ITCI

Reported
Wednesday, March 1

Q4 2022 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.59-0.450.1423.73%
Revenue87.0M87.9M899K1.03%
WhatIF - Earnings
EPS Beat Expectations by $0.14
emptyImageAlt
Intra-Cellular Therapies (ITCI:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything